SantoSolve was founded in 2001 based on the discovery that strontium can have a strong pain killing effect. Experimental treatment of single patients with a topical strontium-containing formulation indicates a rapid, local pain killing effect on both acute and chronic pain at the site of administration. It is anticipated that SantoSolve's products will be alternative or adjuvant products to systemic pain killers used for localized pain. The CEO of the company is Torfinn Ege.